nodes	percent_of_prediction	percent_of_DWPC	metapath
Iohexol—Amylase increased—Vandetanib—thyroid cancer	0.0403	0.0403	CcSEcCtD
Iohexol—Ischaemia—Sorafenib—thyroid cancer	0.0355	0.0355	CcSEcCtD
Iohexol—Hyperthyroidism—Sorafenib—thyroid cancer	0.0328	0.0328	CcSEcCtD
Iohexol—Amylase increased—Sorafenib—thyroid cancer	0.0272	0.0272	CcSEcCtD
Iohexol—Endocrine disorder—Vandetanib—thyroid cancer	0.0232	0.0232	CcSEcCtD
Iohexol—Haematoma—Sorafenib—thyroid cancer	0.0206	0.0206	CcSEcCtD
Iohexol—Myocardial ischaemia—Sorafenib—thyroid cancer	0.0161	0.0161	CcSEcCtD
Iohexol—Endocrine disorder—Sorafenib—thyroid cancer	0.0156	0.0156	CcSEcCtD
Iohexol—Bone disorder—Sorafenib—thyroid cancer	0.0143	0.0143	CcSEcCtD
Iohexol—Cardiac arrest—Vandetanib—thyroid cancer	0.0133	0.0133	CcSEcCtD
Iohexol—Bronchospasm—Vandetanib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Iohexol—Pancreatitis—Vandetanib—thyroid cancer	0.0118	0.0118	CcSEcCtD
Iohexol—Renal failure—Vandetanib—thyroid cancer	0.0106	0.0106	CcSEcCtD
Iohexol—Bradycardia—Vandetanib—thyroid cancer	0.00981	0.00981	CcSEcCtD
Iohexol—Urinary tract disorder—Vandetanib—thyroid cancer	0.00952	0.00952	CcSEcCtD
Iohexol—Urethral disorder—Vandetanib—thyroid cancer	0.00945	0.00945	CcSEcCtD
Iohexol—Pain in extremity—Sorafenib—thyroid cancer	0.0094	0.0094	CcSEcCtD
Iohexol—Eye disorder—Vandetanib—thyroid cancer	0.00901	0.00901	CcSEcCtD
Iohexol—Cardiac disorder—Vandetanib—thyroid cancer	0.00895	0.00895	CcSEcCtD
Iohexol—Angiopathy—Vandetanib—thyroid cancer	0.00875	0.00875	CcSEcCtD
Iohexol—Mediastinal disorder—Vandetanib—thyroid cancer	0.00869	0.00869	CcSEcCtD
Iohexol—Arrhythmia—Vandetanib—thyroid cancer	0.00861	0.00861	CcSEcCtD
Iohexol—Mental disorder—Vandetanib—thyroid cancer	0.00845	0.00845	CcSEcCtD
Iohexol—Dysgeusia—Vandetanib—thyroid cancer	0.00822	0.00822	CcSEcCtD
Iohexol—Muscle spasms—Vandetanib—thyroid cancer	0.00807	0.00807	CcSEcCtD
Iohexol—Pancreatitis—Sorafenib—thyroid cancer	0.00797	0.00797	CcSEcCtD
Iohexol—Tremor—Vandetanib—thyroid cancer	0.00786	0.00786	CcSEcCtD
Iohexol—Loss of consciousness—Vandetanib—thyroid cancer	0.00738	0.00738	CcSEcCtD
Iohexol—Cough—Vandetanib—thyroid cancer	0.00732	0.00732	CcSEcCtD
Iohexol—Convulsion—Vandetanib—thyroid cancer	0.00727	0.00727	CcSEcCtD
Iohexol—Hypertension—Vandetanib—thyroid cancer	0.00725	0.00725	CcSEcCtD
Iohexol—Arthralgia—Vandetanib—thyroid cancer	0.00714	0.00714	CcSEcCtD
Iohexol—Renal failure—Sorafenib—thyroid cancer	0.00712	0.00712	CcSEcCtD
Iohexol—Thrombosis—Epirubicin—thyroid cancer	0.00676	0.00676	CcSEcCtD
Iohexol—Nervous system disorder—Vandetanib—thyroid cancer	0.00672	0.00672	CcSEcCtD
Iohexol—Skin disorder—Vandetanib—thyroid cancer	0.00665	0.00665	CcSEcCtD
Iohexol—Urinary tract disorder—Sorafenib—thyroid cancer	0.00642	0.00642	CcSEcCtD
Iohexol—Urethral disorder—Sorafenib—thyroid cancer	0.00637	0.00637	CcSEcCtD
Iohexol—Thrombosis—Doxorubicin—thyroid cancer	0.00626	0.00626	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Vandetanib—thyroid cancer	0.00624	0.00624	CcSEcCtD
Iohexol—Paraesthesia—Vandetanib—thyroid cancer	0.00615	0.00615	CcSEcCtD
Iohexol—Dyspnoea—Vandetanib—thyroid cancer	0.00611	0.00611	CcSEcCtD
Iohexol—Feeling hot—Epirubicin—thyroid cancer	0.0061	0.0061	CcSEcCtD
Iohexol—Flushing—Sorafenib—thyroid cancer	0.00604	0.00604	CcSEcCtD
Iohexol—Cardiac disorder—Sorafenib—thyroid cancer	0.00604	0.00604	CcSEcCtD
Iohexol—Gastrointestinal disorder—Vandetanib—thyroid cancer	0.00591	0.00591	CcSEcCtD
Iohexol—Angiopathy—Sorafenib—thyroid cancer	0.0059	0.0059	CcSEcCtD
Iohexol—Immune system disorder—Sorafenib—thyroid cancer	0.00587	0.00587	CcSEcCtD
Iohexol—Injection site pain—Epirubicin—thyroid cancer	0.00586	0.00586	CcSEcCtD
Iohexol—Mediastinal disorder—Sorafenib—thyroid cancer	0.00586	0.00586	CcSEcCtD
Iohexol—Pain—Vandetanib—thyroid cancer	0.00586	0.00586	CcSEcCtD
Iohexol—Arrhythmia—Sorafenib—thyroid cancer	0.00581	0.00581	CcSEcCtD
Iohexol—Mental disorder—Sorafenib—thyroid cancer	0.0057	0.0057	CcSEcCtD
Iohexol—Erythema—Sorafenib—thyroid cancer	0.00566	0.00566	CcSEcCtD
Iohexol—Feeling hot—Doxorubicin—thyroid cancer	0.00564	0.00564	CcSEcCtD
Iohexol—Gastrointestinal pain—Vandetanib—thyroid cancer	0.0056	0.0056	CcSEcCtD
Iohexol—Dysgeusia—Sorafenib—thyroid cancer	0.00554	0.00554	CcSEcCtD
Iohexol—Extravasation—Epirubicin—thyroid cancer	0.00549	0.00549	CcSEcCtD
Iohexol—Muscle spasms—Sorafenib—thyroid cancer	0.00544	0.00544	CcSEcCtD
Iohexol—Injection site pain—Doxorubicin—thyroid cancer	0.00542	0.00542	CcSEcCtD
Iohexol—Abdominal pain—Vandetanib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Iohexol—Body temperature increased—Vandetanib—thyroid cancer	0.00541	0.00541	CcSEcCtD
Iohexol—Bone disorder—Epirubicin—thyroid cancer	0.0053	0.0053	CcSEcCtD
Iohexol—Angioedema—Sorafenib—thyroid cancer	0.00517	0.00517	CcSEcCtD
Iohexol—Syncope—Sorafenib—thyroid cancer	0.00508	0.00508	CcSEcCtD
Iohexol—Extravasation—Doxorubicin—thyroid cancer	0.00508	0.00508	CcSEcCtD
Iohexol—Loss of consciousness—Sorafenib—thyroid cancer	0.00498	0.00498	CcSEcCtD
Iohexol—Cough—Sorafenib—thyroid cancer	0.00494	0.00494	CcSEcCtD
Iohexol—Bone disorder—Doxorubicin—thyroid cancer	0.0049	0.0049	CcSEcCtD
Iohexol—Hypertension—Sorafenib—thyroid cancer	0.00489	0.00489	CcSEcCtD
Iohexol—Pruritus—Vandetanib—thyroid cancer	0.00485	0.00485	CcSEcCtD
Iohexol—Neck pain—Epirubicin—thyroid cancer	0.00484	0.00484	CcSEcCtD
Iohexol—Arthralgia—Sorafenib—thyroid cancer	0.00482	0.00482	CcSEcCtD
Iohexol—Injection site reaction—Epirubicin—thyroid cancer	0.00476	0.00476	CcSEcCtD
Iohexol—Diarrhoea—Vandetanib—thyroid cancer	0.00469	0.00469	CcSEcCtD
Iohexol—Anaphylactic shock—Sorafenib—thyroid cancer	0.00462	0.00462	CcSEcCtD
Iohexol—Shock—Sorafenib—thyroid cancer	0.00455	0.00455	CcSEcCtD
Iohexol—Nervous system disorder—Sorafenib—thyroid cancer	0.00453	0.00453	CcSEcCtD
Iohexol—Dizziness—Vandetanib—thyroid cancer	0.00453	0.00453	CcSEcCtD
Iohexol—Skin disorder—Sorafenib—thyroid cancer	0.00449	0.00449	CcSEcCtD
Iohexol—Neck pain—Doxorubicin—thyroid cancer	0.00448	0.00448	CcSEcCtD
Iohexol—Injection site reaction—Doxorubicin—thyroid cancer	0.0044	0.0044	CcSEcCtD
Iohexol—Vomiting—Vandetanib—thyroid cancer	0.00435	0.00435	CcSEcCtD
Iohexol—Rash—Vandetanib—thyroid cancer	0.00432	0.00432	CcSEcCtD
Iohexol—Dermatitis—Vandetanib—thyroid cancer	0.00431	0.00431	CcSEcCtD
Iohexol—Headache—Vandetanib—thyroid cancer	0.00429	0.00429	CcSEcCtD
Iohexol—Pulmonary oedema—Epirubicin—thyroid cancer	0.00426	0.00426	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.00421	0.00421	CcSEcCtD
Iohexol—Dyspnoea—Sorafenib—thyroid cancer	0.00412	0.00412	CcSEcCtD
Iohexol—Nausea—Vandetanib—thyroid cancer	0.00407	0.00407	CcSEcCtD
Iohexol—Thrombophlebitis—Epirubicin—thyroid cancer	0.00401	0.00401	CcSEcCtD
Iohexol—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.00399	0.00399	CcSEcCtD
Iohexol—Pain—Sorafenib—thyroid cancer	0.00395	0.00395	CcSEcCtD
Iohexol—Pulmonary oedema—Doxorubicin—thyroid cancer	0.00394	0.00394	CcSEcCtD
Iohexol—Gastrointestinal pain—Sorafenib—thyroid cancer	0.00378	0.00378	CcSEcCtD
Iohexol—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00371	0.00371	CcSEcCtD
Iohexol—Urticaria—Sorafenib—thyroid cancer	0.00367	0.00367	CcSEcCtD
Iohexol—Abdominal pain—Sorafenib—thyroid cancer	0.00365	0.00365	CcSEcCtD
Iohexol—Body temperature increased—Sorafenib—thyroid cancer	0.00365	0.00365	CcSEcCtD
Iohexol—Anaphylactoid reaction—Epirubicin—thyroid cancer	0.00359	0.00359	CcSEcCtD
Iohexol—Pain in extremity—Epirubicin—thyroid cancer	0.00347	0.00347	CcSEcCtD
Iohexol—Hypersensitivity—Sorafenib—thyroid cancer	0.0034	0.0034	CcSEcCtD
Iohexol—Anaphylactoid reaction—Doxorubicin—thyroid cancer	0.00332	0.00332	CcSEcCtD
Iohexol—Cardiac arrest—Epirubicin—thyroid cancer	0.0033	0.0033	CcSEcCtD
Iohexol—Pruritus—Sorafenib—thyroid cancer	0.00327	0.00327	CcSEcCtD
Iohexol—Pain in extremity—Doxorubicin—thyroid cancer	0.00321	0.00321	CcSEcCtD
Iohexol—Diarrhoea—Sorafenib—thyroid cancer	0.00316	0.00316	CcSEcCtD
Iohexol—Muscular weakness—Epirubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Iohexol—Cardiac arrest—Doxorubicin—thyroid cancer	0.00306	0.00306	CcSEcCtD
Iohexol—Dizziness—Sorafenib—thyroid cancer	0.00306	0.00306	CcSEcCtD
Iohexol—Pancreatitis—Epirubicin—thyroid cancer	0.00294	0.00294	CcSEcCtD
Iohexol—Vomiting—Sorafenib—thyroid cancer	0.00294	0.00294	CcSEcCtD
Iohexol—Rash—Sorafenib—thyroid cancer	0.00291	0.00291	CcSEcCtD
Iohexol—Dermatitis—Sorafenib—thyroid cancer	0.00291	0.00291	CcSEcCtD
Iohexol—Headache—Sorafenib—thyroid cancer	0.00289	0.00289	CcSEcCtD
Iohexol—Muscular weakness—Doxorubicin—thyroid cancer	0.00284	0.00284	CcSEcCtD
Iohexol—Nausea—Sorafenib—thyroid cancer	0.00274	0.00274	CcSEcCtD
Iohexol—Pancreatitis—Doxorubicin—thyroid cancer	0.00272	0.00272	CcSEcCtD
Iohexol—Renal failure—Epirubicin—thyroid cancer	0.00263	0.00263	CcSEcCtD
Iohexol—Bradycardia—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Iohexol—Renal failure—Doxorubicin—thyroid cancer	0.00244	0.00244	CcSEcCtD
Iohexol—Urinary tract disorder—Epirubicin—thyroid cancer	0.00237	0.00237	CcSEcCtD
Iohexol—Urethral disorder—Epirubicin—thyroid cancer	0.00236	0.00236	CcSEcCtD
Iohexol—Bradycardia—Doxorubicin—thyroid cancer	0.00226	0.00226	CcSEcCtD
Iohexol—Eye disorder—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Iohexol—Flushing—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Iohexol—Cardiac disorder—Epirubicin—thyroid cancer	0.00223	0.00223	CcSEcCtD
Iohexol—Urinary tract disorder—Doxorubicin—thyroid cancer	0.0022	0.0022	CcSEcCtD
Iohexol—Angiopathy—Epirubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Urethral disorder—Doxorubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Iohexol—Immune system disorder—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Iohexol—Mediastinal disorder—Epirubicin—thyroid cancer	0.00217	0.00217	CcSEcCtD
Iohexol—Arrhythmia—Epirubicin—thyroid cancer	0.00215	0.00215	CcSEcCtD
Iohexol—Mental disorder—Epirubicin—thyroid cancer	0.00211	0.00211	CcSEcCtD
Iohexol—Erythema—Epirubicin—thyroid cancer	0.00209	0.00209	CcSEcCtD
Iohexol—Eye disorder—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Iohexol—Flushing—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Cardiac disorder—Doxorubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Flatulence—Epirubicin—thyroid cancer	0.00206	0.00206	CcSEcCtD
Iohexol—Dysgeusia—Epirubicin—thyroid cancer	0.00205	0.00205	CcSEcCtD
Iohexol—Angiopathy—Doxorubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Iohexol—Muscle spasms—Epirubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Iohexol—Immune system disorder—Doxorubicin—thyroid cancer	0.00201	0.00201	CcSEcCtD
Iohexol—Mediastinal disorder—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Iohexol—Arrhythmia—Doxorubicin—thyroid cancer	0.00199	0.00199	CcSEcCtD
Iohexol—Mental disorder—Doxorubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Iohexol—Erythema—Doxorubicin—thyroid cancer	0.00194	0.00194	CcSEcCtD
Iohexol—Flatulence—Doxorubicin—thyroid cancer	0.00191	0.00191	CcSEcCtD
Iohexol—Dysgeusia—Doxorubicin—thyroid cancer	0.0019	0.0019	CcSEcCtD
Iohexol—Malaise—Epirubicin—thyroid cancer	0.00189	0.00189	CcSEcCtD
Iohexol—Syncope—Epirubicin—thyroid cancer	0.00188	0.00188	CcSEcCtD
Iohexol—Muscle spasms—Doxorubicin—thyroid cancer	0.00186	0.00186	CcSEcCtD
Iohexol—Loss of consciousness—Epirubicin—thyroid cancer	0.00184	0.00184	CcSEcCtD
Iohexol—Cough—Epirubicin—thyroid cancer	0.00183	0.00183	CcSEcCtD
Iohexol—Convulsion—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Iohexol—Hypertension—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Iohexol—Arthralgia—Epirubicin—thyroid cancer	0.00178	0.00178	CcSEcCtD
Iohexol—Discomfort—Epirubicin—thyroid cancer	0.00176	0.00176	CcSEcCtD
Iohexol—Malaise—Doxorubicin—thyroid cancer	0.00175	0.00175	CcSEcCtD
Iohexol—Syncope—Doxorubicin—thyroid cancer	0.00174	0.00174	CcSEcCtD
Iohexol—Confusional state—Epirubicin—thyroid cancer	0.00172	0.00172	CcSEcCtD
Iohexol—Anaphylactic shock—Epirubicin—thyroid cancer	0.00171	0.00171	CcSEcCtD
Iohexol—Loss of consciousness—Doxorubicin—thyroid cancer	0.0017	0.0017	CcSEcCtD
Iohexol—Cough—Doxorubicin—thyroid cancer	0.00169	0.00169	CcSEcCtD
Iohexol—Shock—Epirubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Iohexol—Convulsion—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Iohexol—Nervous system disorder—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Iohexol—Hypertension—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Iohexol—Skin disorder—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Iohexol—Arthralgia—Doxorubicin—thyroid cancer	0.00165	0.00165	CcSEcCtD
Iohexol—Discomfort—Doxorubicin—thyroid cancer	0.00163	0.00163	CcSEcCtD
Iohexol—Hypotension—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Iohexol—Confusional state—Doxorubicin—thyroid cancer	0.00159	0.00159	CcSEcCtD
Iohexol—Anaphylactic shock—Doxorubicin—thyroid cancer	0.00158	0.00158	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.00156	0.00156	CcSEcCtD
Iohexol—Shock—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Iohexol—Nervous system disorder—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Iohexol—Skin disorder—Doxorubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Iohexol—Paraesthesia—Epirubicin—thyroid cancer	0.00153	0.00153	CcSEcCtD
Iohexol—Dyspnoea—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Iohexol—Somnolence—Epirubicin—thyroid cancer	0.00152	0.00152	CcSEcCtD
Iohexol—Hypotension—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Iohexol—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.00147	0.00147	CcSEcCtD
Iohexol—Pain—Epirubicin—thyroid cancer	0.00146	0.00146	CcSEcCtD
Iohexol—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Iohexol—Paraesthesia—Doxorubicin—thyroid cancer	0.00142	0.00142	CcSEcCtD
Iohexol—Dyspnoea—Doxorubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Iohexol—Feeling abnormal—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Iohexol—Somnolence—Doxorubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Iohexol—Gastrointestinal pain—Epirubicin—thyroid cancer	0.0014	0.0014	CcSEcCtD
Iohexol—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Iohexol—Urticaria—Epirubicin—thyroid cancer	0.00136	0.00136	CcSEcCtD
Iohexol—Pain—Doxorubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Iohexol—Body temperature increased—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Iohexol—Abdominal pain—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Iohexol—Feeling abnormal—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Iohexol—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.00129	0.00129	CcSEcCtD
Iohexol—Hypersensitivity—Epirubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Iohexol—Urticaria—Doxorubicin—thyroid cancer	0.00126	0.00126	CcSEcCtD
Iohexol—Abdominal pain—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Iohexol—Body temperature increased—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Iohexol—Pruritus—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Iohexol—Diarrhoea—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Iohexol—Hypersensitivity—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Iohexol—Dizziness—Epirubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Iohexol—Pruritus—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Iohexol—Vomiting—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Iohexol—Diarrhoea—Doxorubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Iohexol—Rash—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Iohexol—Dermatitis—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Iohexol—Headache—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Iohexol—Dizziness—Doxorubicin—thyroid cancer	0.00104	0.00104	CcSEcCtD
Iohexol—Nausea—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Iohexol—Vomiting—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Iohexol—Rash—Doxorubicin—thyroid cancer	0.000996	0.000996	CcSEcCtD
Iohexol—Dermatitis—Doxorubicin—thyroid cancer	0.000995	0.000995	CcSEcCtD
Iohexol—Headache—Doxorubicin—thyroid cancer	0.00099	0.00099	CcSEcCtD
Iohexol—Nausea—Doxorubicin—thyroid cancer	0.000938	0.000938	CcSEcCtD
